Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?

Numerous studies show a modification of the gut microbiota in patients with obesity or diabetes. Animal studies have also shown a causal role of gut microbiota in liver metabolic disorders including steatosis whereas the human situation is less clear. Patients with metabolic dysfunction associated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanthier, Nicolas, Delzenne, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454620/
https://www.ncbi.nlm.nih.gov/pubmed/36078124
http://dx.doi.org/10.3390/cells11172718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454620/
https://www.ncbi.nlm.nih.gov/pubmed/36078124
http://dx.doi.org/10.3390/cells11172718

Ejemplares similares